Junda (David) Dai represents a variety of European and US clients in their direct investments in China, including green-field investments, cross-border mergers and acquisitions (M&A), venture capital and private equity investments, and strategic alliances. Leveraging more than 15 years of post-qualification experience, he advises clients, including many Fortune 500 companies, in a wide range of industries and areas, from manufacturing, infrastructure, telecommunications, media and technology (TMT), chemicals and energy, to health care, life science and agriculture. David is co-head of the Corporate Advisory Group. Show More
Junda (David) Dai represents a variety of European and US clients in their direct investments in China, including green-field investments, cross-border mergers and acquisitions (M&A), venture capital and private equity investments, and strategic alliances. Leveraging more than 15 years of post-qualification experience, he advises clients, including many Fortune 500 companies, in a wide range of industries and areas, from manufacturing, infrastructure, telecommunications, media and technology (TMT), chemicals and energy, to health care, life science and agriculture. David is co-head of the Corporate Advisory Group.
David has a special interest in the complicated compliance matters that surround business activity of multinationals in China and the resolution of international commercial disputes. He has a track record of proposing, negotiating and achieving solutions in a variety of matters related to foreign exchange, state-owned assets, environmental protection and commercial bribery.
David is a frequently published author on topics of Chinese law and practice in the areas of M&A, corporate and dispute resolutions.
Advised a world-leading information technology company on various regulatory issues related to the medical data management software services it provided to Chinese customers via cloud computing, including the value-added telecommunication service licensure requirement and data privacy and security issues
Counseled a world-leading chemical and nutrition company in the formation of its strategic cooperation partnership with a local major Chinese chemical manufacturer; services included cooperation structure analysis, legal and compliance due diligence on the local partner, drafting and negotiating strategic cooperation agreement, and related transactional agreements
Counseled a leading US-based dairy enterprise in forming its strategic partnership cooperation with a leading Chinese dairy company to establish a large-scale powdered milk production center in the United States by reviewing and negotiating all relevant transaction agreements
Counseled a US-based health care institution on their business strategy to establish multiple health care clinics in China, advising on Chinese regulatory approvals, business structures to work with local joint venture partners, and definitive agreements to form joint venture health care institutions and management companies
Counseled a Fortune 500 company in its acquisition of a leading Chinese chemical feedstock manufacturer and provided legal opinions on various related compliance issues regarding the management buyout of the state-owned enterprise and offshore nominee equity structures of the target company
Advised a leading global food company on its business restructure project in China and on various technical and regulatory issues related to its restructure plan and related solutions, including the comparison analysis on merger or liquidation opinions in terms of tax, labor, liability, succession and other regulatory issues
Provided comprehensive legal services to a US-based private equity firm in its acquisition of Chinese enterprises in various business lines, including legal structure design, legal due diligence, and negotiation and drafting of definitive agreements, as well as handling post-closing issues such as actual control, shareholder information rights, regulatory compliance and dispute resolution
Advised the board of directors of a multinational doing business in China on legal risks related to its Chinese subsidiary violating the environmental protection law in China, including proposing solutions
Provided full legal services for a Fortune 500 company in connection with the handling of a multimillion-RMB administrative penalty proposed by the State Administration of Foreign Exchange (SAFE), including in-depth risk analysis, formulating a legal strategy to deal with SAFE, drafting communications and correspondence with SAFE, attending the hearing held by SAFE and negotiating a final resolution of the matter with SAFE
Represented a US-based private equity fund, winning an interim award regarding jurisdiction and a partial award on the key disputed issue without discovery in a multimillion-dollar dispute with our client’s Chinese partners under a share-purchase agreement at the Hong Kong International Arbitration Center, which led to a favorable settlement for our client
The affiliated firms of MWE China Law Offices and McDermott Will & Emery have lawyers educated and qualified in China, the United States and Europe. Together, the firms are able to staff Chinese cross-border projects with lawyers who are qualified and experienced in China and in the other country involved in the project.
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.